SCHEMBL2290751

SCHEMBL2290751

CCCCCCC(C)c1cc(O)c(-c2c(O)cc(C(C)CCCCCC)cc2C(C)(C)C)c(C(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.39
GPR84 Q9NQS5 1/20 0.38
CYP2D6 P10635 2/20 0.36
ALOX15 P16050 2/20 0.36
TP53 P04637 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
GAA P10253 1/20 0.35
XBP1 P17861 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADRB2 P07550 4/20 0.34
CA2 P00918 2/20 0.33
CYP1A2 P05177 2/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2289500 0.98 KDR (0.37) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL2293692 0.94 GAA (0.39) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL10775543 0.86 CA2 (0.41) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL3117187 0.86 CA2 (0.41) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL10774687 0.86 CA2 (0.41) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL28045345 0.86 CA2 (0.41) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL14976954 0.86 CA2 (0.41) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL11805953 0.86 CA2 (0.41) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL11848726 0.86 CA2 (0.41) KDRGPR84CYP2D6ALOX15TP53
SCHEMBL10081832 0.84 CA2 (0.42) GPR84CYP2D6ALOX15TP53CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346887-B1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES DOW TECHNOLOGY INVESTMENTS LLC (US) 2013-12-25 EP disclosed
US-8546600-B2 Slurry process for synthesis of bisphosphites and situ use thereof for producing bisphosphite DOW TECHNOLOGY INVESTMENTS LLC 2013-10-01 US disclosed
US-20110196166-A1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE DOW TECHNOLOGY INVESTMENTS LLC 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196166-A1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE SOST, PLCB3, PPIP5K2 KDR 1898/4885GPR84 4028/4885CYP2D6 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.